Brain abscess: Difference between revisions
(→DDX) |
|||
| Line 27: | Line 27: | ||
==DDX== | ==DDX== | ||
#CVA | #[[CVA]] | ||
#Meningitis | #[[Meningitis]] | ||
#Malignancy | #Malignancy | ||
Revision as of 09:08, 5 December 2011
Background
- Caused by one of three methods:
- Hematogenous spread (33%)
- Contiguous infection from middle ear, sinus, teeth (33%)
- Direct implantation by surgery or penetrating trauma (10%)
- Microbiology
- Anaerobes and Gram-negative rods are typical pathogens
- Staph is involved with direct implantation cases
Clinical Features
- Pts rarely appear acutely ill
- Classic traid of HA, fever, AND focal neuro deficit is present in <33%
- Headache is most common symptom (present in almost all cases)
- Fever (~50% of pts)
- Focal neuro symptoms or seizure (~33% of pts)
- Neck stiffness (<50% of pts)
- Signs of increased ICP: vomiting, confusion, obtundation (50% of pts)
Diagnosis
- CT with contrast
- Ring enhancing lesion surrounding low-density center surrounded by white matter edema
- Early in course ring may be less defined; CT may only show area of focal hypodensity
Work-Up
- Head CT w/ contrast
- Blood cx
DDX
- CVA
- Meningitis
- Malignancy
Treatment
- Abx
- Otogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
- Sinogenic or odontogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
- Penetrating trauma or neurosurgical procedures
- Vancomycin 15mg/kg IV q12hr + ceftazidime 2gm IV q8hr
- Hematogenous source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
- No obvious source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
- Otogenic source
Disposition
- Neurosurgery consultation
Source
Tintinalli
